The number of people who have the gene that causes Huntington's disease in Northern Scotland has been accurately counted for ...

AMT-130 is administered through magnetic resonance imaging-guided, convection-enhanced stereotactic neurosurgical delivery into the striatum.

Breakthrough Therapy designation based on clinical evidence from Phase I/II trials showing meaningful slowing of disease progression ~~ ...

Gene therapy developer uniQure shares soared 46% in premarket trading after its treatment for Huntington's disease received breakthrough therapy designation from the Food and Drug Administration.

Qure (NASDAQ:QURE) shares added ~39% in the premarket on Thursday after the Dutch biotech announced that the FDA granted ...

The rate in the area is 14.5 per 100,000 people, more than five times the estimated worldwide rate of 2.71 per 100,000 people ...

If a diagnosis of CJD is suspected, even if the initial imaging is reported as normal, a specialist MRI review either by an experienced neuroradiologist or by a prion disease specialist unit could ...

A drug originally developed for high blood pressure could find a new use in the treatment of Huntington's disease, thanks to an artificial intelligence-based drug discovery programme at Spain's ...

Roche has stopped dosing in a phase 3 trial of tominersen, a potential Huntington’s disease (HD) drug developed with Ionis, after a pre-planned review by independent experts.

Apr. 15, 2025 — The smallest control system of vision in mammals has been mapped -- a discovery that opens entirely new insights into how our vision works and how it can be affected by ..

Inspired by how a ... New Study Links Lower Proportions of Certain Sleep Stages to Brain Changes Associated With Alzheimer's Disease Mar. 31, 2025 — New research reveals that lower proportions ...

A new NHS diagnostic centre which will offer thousands of extra MRI scans to people in Surrey ... to identify illnesses such as cancer and heart disease more quickly and ensure patients receive ...